An appeals court in D.C. said a suit PCMA filed against a D.C. law can go ahead in a lower court.
The
Sulbactam-Durlobactam for Bacterial Pneumonia Gets FDA Approval
May 24th 2023The antibiotic, marketed as Xacduro, is indicated for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by susceptible strains of bacteria called Acinetobacter baumannii.
2 Clarke Drive
Cranbury, NJ 08512